Clinical Trials Arena

How to effectively incorporate PROMs in oncology trials

Clinical Trials Arena spoke to Anthony T. Everhart, MD, FACP; Clinical Vice President at leading evidence generation company, Signant Health,…

Flexibility in crisis: Disaster preparedness in clinical trials

From the Covid-19 pandemic to wars to natural disasters, the medical industry has faced a turbulent five years. In places…

Bristol Myers Squibb’s Sotyktu shows long-term efficacy for plaque psoriasis

Bristol Myers Squibb has presented three-year results from the POETYK PSO long-term extension trial (NCT04036435) of Sotyktu (deucravacitinib) for the…

Signal: UK clinical research provider Ergomed bought out in $888m deal

UK private equity firm Permira has announced an agreement to purchase Ergomed for £703m ($888.1m). Ergomed specialises in clinical trial…

MapLight mulls muscarinic therapy for Alzheimer’s disease

MapLight Therapeutics plans to start Phase II trials to evaluate the combination treatment of M1/M4 muscarinic receptor agonist (ML-007) and…

Cellectis to focus on CAR-T cell therapies in 2023

Cellectis has provided an update on three clinical trials AMELI-01, BALLI-01 and NATHALI-01 evaluating its three chimeric antigen receptor (CAR)…

Addex wins $3m to research substance use therapy

Addex Therapeutics and Indivior have extended their research agreement for the drug discovery of novel oral gamma-aminobutyric acid subtype B…

Closure of the National Cancer Research Institute: UK cancer research landscape takes a hit

In June 2023, a closure announcement from the National Cancer Research Institute (NCRI) shook the UK cancer community. The charity…

UK Government faces an uphill battle to restore clinical trials in the country

Aside from evaluating the safety and efficacy of a drug or device, clinical trials play other crucial roles. Lord O’Shaughnessy’s…

Vivoryon issues updates on its Alzheimer’s therapy programme

Netherlands-based Vivoryon Therapeutics has provided updates on its clinical development programme for varoglutamstat for treating Alzheimer’s disease (AD), including clinical…